Xue Wei
305 Zhongshan East Road
Nanjing, 210002, China
Nanjing, 210002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Arginase 1 as a candidate immune-metabolic biomarker in lumbar disc herniation: integrated bioinformatics, experimental validation, and clinical evidence.
Journal: Journal of molecular histology
Published: May 07, 2026
GPNMB expression differentiates subependymal giant cell astrocytoma from other mimickers.
Journal: Annals of diagnostic pathology
Published: December 02, 2024
Recording the Centric Relation in an Edentulous Patient Using the Existing Complete Denture Mounted with Gothic Arch Tracer.
Journal: Case reports in dentistry
Published: August 18, 2021
The use of gene-modified bone marrow mesenchymal stem cells for cochlear cell therapy.
Journal: Transplant immunology
Published: May 26, 2021
Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum.
Journal: The American journal of surgical pathology
Published: November 26, 2019
Differential expression of EphA5 protein in gastric carcinoma and its clinical significance.
Journal: Oncology letters
Published: November 03, 2017
Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.
Journal: The American journal of surgical pathology
Published: March 14, 2017
EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.
Journal: Journal of ovarian research
Published: August 17, 2016
Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: July 14, 2016
BRM/SMARCA2-negative clear cell renal cell carcinoma is associated with a high percentage of BRM somatic mutations, deletions and promoter methylation.
Journal: Histopathology
Published: May 12, 2016
Last Updated: 09/26/2026